The Bulletin
The Times


.

Ractigen's RAG-17 ALS Data Shines at AAN 2025: Earns Top Award, Phase I Advances

  • Written by PR Newswire
  • Final results from an Investigator-Initiated Trial presented for the first time, demonstrating favorable safety, significant target engagement, and encouraging clinical & biomarker signals
  • Abstract honored with prestigious "Abstracts of Distinction" award by AAN Science Committee, recognizing top quality and interest
  • Phase I clinical trial for...
hacklink esim balkanzlibraryzlibraryz-libraryFanatikbetmarsbahisvsf watchesjojobetuk casinos not on gamstopGamStopgrandpashabet resmi giriş